-
Trump Nears Marijuana Reclassification Move
The Trump administration is expected to move soon to reclassify marijuana from Schedule I to Schedule III under federal law, according to Axios - a step that would ease restrictions on medical research but would not legalize it.
-
Trump Is Taking on Big Pharma - It's Long Overdue
The pharmaceutical industry has gotten very good at shifting blame. If prices go up, it's someone else's fault: insurers, hospitals, middlemen. Anyone but the companies actually setting the prices.
-
Gas Prices Skyrocketing: Here's the Real Reason
Gas prices aren't confusing by accident; they're confusing by design. Every time prices spike, the same narrative gets pushed: blame the station, blame "greedy oil companies," blame anything visible and easy to point at.
-
Gold 'Buy the Dip' Call Emerges as Prices Hold Near Highs
Gold is holding near record territory and sending a clear signal to investors: short-term weakness may be an opportunity, not a warning.
-
Report Calls for More Scrutiny in FDA Drug Approvals
The U.S. Food and Drug Administration should be more transparent when granting accelerated approval for certain drugs, the Institute for Clinical and Economic Review, an influential drug pricing body, said in a report Thursday.
-
Volatility Funds Flip the Script on March Selloff
The heaviest stock selling by volatility-linked funds appears to have largely run its course last month, potentially setting up U.S. indexes for gains should market swings subside in coming weeks.
-
The Stock Market Rally: Buy or Fade
Last week, the stock market rally was one of the best performances in nearly a year. The S&P 500 surged 3.4%, the Nasdaq climbed 4.4%, and the bulls declared the correction over.
-
Traders Bet $950 Million on Oil Decline Ahead of Ceasefire
Investors placed an approximately $950 million bet on oil prices falling just hours before the U.S. and Iran announced a ceasefire, the latest large wager on the direction of the world's most traded commodity ahead of a major policy announcement by President Donald Trump.
-
Blue Owl Curbs Withdrawals; Asset Manager Shares Slide
Shares of U.S. alternative asset managers fell on Thursday after Blue Owl capped the amount investors can withdraw from two of its retail-focused funds, stoking fresh concerns about the industry.
-
Record Q1 Megadeals Propel Global M&A Gains
Turbulence linked to the war in Iran and swings in valuations have yet to deter corporate deal-making as transactions in the first quarter exceeded $1.2 trillion, LSEG data shows, and dealmakers say much more is in the pipeline.
-
Tech Stocks Struggle for Safe Haven Appeal in Iran Market Fallout
Technology shares are struggling to act as safe havens in the turbulence wrought by the Iran conflict - and that could be a big problem for the broader U.S. stock market.
-
Trump Taps Zuckerberg, Ellison, Huang for Tech Panel
President Trump is assembling a high-profile group of technology and business leaders - including Meta CEO Mark Zuckerberg, Oracle Executive Chairman Larry Ellison and Nvidia CEO Jensen Huang - to serve on a new advisory council focused on artificial intelligence and...
-
New Group Launches Push for Tougher AI Rules
A new coalition of conservative organizations advocating stricter online safety protections for children and increased oversight of artificial intelligence launched Monday, entering a rapidly evolving debate over how aggressively the United States should regulate emerging...
-
Easter Chocolate Prices Stay High Despite Cocoa Crash
Prices for chocolate eggs and bunnies will remain high this Easter in the United States despite the fact that prices for the main raw material used to make them , cocoa beans , have gone sharply down over the last year, a report said Friday.
-
Generic Ozempic to Soon Reach Billions of People
The Danish drug manufacturer Novo Nordisk is losing the patent for its popular weight loss drug semaglutide, sold as Wegovy for obesity and Ozempic for Type 2 diabetes. The patent expires Saturday in India, China and other heavy populated nations which opens the door for...
-
$200 Oil No Longer Crazy as Mideast Supply Shock Deepens
Global oil markets were jolted this week as crude prices surged past $114 per barrel in London trading after Israel bombed a key Iranian gas field and Iran struck Qatar's major Liquefied Natural Gas (LNG) plant.
-
AI Fears Contribute to Hollywood Labor Showdown
Just weeks before a new round of high-stakes Hollywood labor negotiations, the Writers Guild of America West is facing turmoil inside its own ranks – with staffers launching a strike over artificial intelligence protections and alleged unfair labor practices.
-
New Cancer Immunotherapy Killed Whole Tumors
Researchers at Rockefeller University are reporting encouraging results from an early clinical trial of a redesigned cancer immunotherapy that is injected directly into tumors. In the small study, six of 12 patients experienced tumor shrinkage, and two patients went into...
-
US Airlines See Strong Spring Demand Even as Fuel Costs Jump
U.S. airlines Tuesday reported stronger-than-expected travel demand heading into the spring, supporting higher fares and revenue growth, even as a surge in jet fuel prices linked to the Iran war has pushed operating costs higher.
-
Soros CEO & CIO Warns of a Reckoning
Dawn Fitzpatrick, CEO of Soros Fund Management, says overallocated LPs, frozen distributions, and mounting margin-call risk are converging into a sector-wide shakeout.
-
Trump Rescinds the EV Fuel Economy Math Rule That Was a Lie!
For years, Washington sold Americans a fantasy wrapped in a window sticker. We all saw huge MPGe numbers on window stickers, but they just seemed unreal. Because they are!
-
AI Work Utopia Isn't Happening-It's Making Jobs Busier
The promise of an AI-driven work utopia , where technology frees employees from routine tasks and gives them more time for creative thinking , isn't materializing. Instead, artificial intelligence appears to be making the modern workplace faster, busier and more demanding,...
-
Prices for New Cars Have Soared. Here's One Big Reason Why
The U.S. car business is grappling with a stubborn affordability problem, one that threatens to relegate more Americans to the used-car lot and leave automakers vulnerable to lower-priced rivals.
-
Senate Green Lights ChatGPT, Copilot for Staff
Artificial intelligence has officially arrived on Capitol Hill. Senate aides have now been cleared to use ChatGPT and other A.I. chatbots for official work, according to new internal guidance from the Senate's technology office.
-
States Brace for Trump Admin Report on AI Laws
State legislatures across the country are bracing for the announcement on which of their laws will be declared "onerous" in a Commerce Department report due by March 11.